Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.36 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 3/20 | 0.34 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | USP5 | P45974 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4903657 | 0.86 | SLC29A1 (0.38) | MEN1KMT2ATP53PABPC1SLC29A1 | |
| SCHEMBL6177913 | 0.85 | MEN1 (0.40) | MEN1KMT2ATP53PABPC1HPGD | |
| SCHEMBL24999134 | 0.80 | ADORA2A (0.45) | MEN1KMT2ATP53PABPC1SLC29A1 | |
| SCHEMBL4891900 | 0.78 | KDM4E (0.33) | MEN1KMT2ATP53PABPC1SLC29A1 | |
| SCHEMBL4897940 | 0.77 | DUT (0.34) | MEN1KMT2ASLC29A1 | |
| SCHEMBL1106478 | 0.76 | PDE4A (0.43) | MEN1KMT2ATP53PABPC1CDK1 | |
| SCHEMBL1742735 | 0.72 | ADA (0.64) | HSD17B10KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL4865265 | 0.70 | MEN1 (0.37) | MEN1KMT2ATP53PABPC1HPGD | |
| SCHEMBL21125746 | 0.69 | ADA (0.41) | — | |
| SCHEMBL5016756 | 0.67 | MEN1 (0.52) | MEN1KMT2ATP53PABPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080318878-A1 | Antibacterial Agents | RANBAXY LABORATRIES LIMITED (IN) | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080318878-A1 | Antibacterial Agents | MLX, MGAM, CAT | MEN1 3417/4885KMT2A 1681/4885TP53 4324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.